Doctor of Podiatric Medicine Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Victoria Lellis

Podiatrist, Foot & Ankle Surgery Cranston, RI Doctor of Podiatric Medicine

NPI 1922682749 CMS profile 9959409

1591 Cranston St, Cranston, RI 02920

Open in the dashboard

General payments

$8,270

77 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Victoria Lellis of Cranston, RI is reported in the CMS Open Payments database as having received $8,270 across 77 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $848 21
2024 General $3,436 31
2023 General $957 10
2022 General $2,893 13
2021 General $136 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Victoria Lellis
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Victoria Lellis were reported at $848. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Victoria Lellis Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $0 $389 $118–$1,406 $163
2020 $0 $191 $62–$691 $114
2021 $136 $329 $104–$1,341 $132
2022 $2,893 $419 $125–$1,611 $149
2023 $957 $377 $128–$1,164 $160
2024 $3,436 $394 $134–$1,168 $164
2025 $848 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Kairos Surgical Inc $2,423 4 payments
  2. Stryker Corporation $2,073 19 payments
  3. Medline Industries, Inc. $1,276 8 payments
  4. Treace Medical Concepts, Inc. $1,261 16 payments
  5. Zimmer Biomet Holdings, Inc. $203 4 payments
  6. Smith+Nephew, Inc. $177 4 payments
  7. Acumed LLC $168 3 payments
  8. Integra LifeSciences Corporation $135 2 payments
  9. Bioventus LLC $123 3 payments
  10. Linvatec Corporation $118 1 payment
  11. Other $313 13 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,062 63 payments
  2. Travel and Lodging $2,807 12 payments
  3. Education $2,400 2 payments
Products named General payments · program years 2021–2025
  1. ORTHOLOC 3DI $1,106 15 payments
  2. LAPIPLASTY SYSTEM $942 11 payments
  3. ORTHOLOC 2 LAPIFUSE $879 3 payments
  4. TMC SPEEDMTP $220 3 payments
  5. ACUMED $168 3 payments
  6. Integra Recon-Skin And Wound $135 2 payments
  7. Integra Recon-Skin And Wound $135 2 payments
  8. Integra Recon-Skin And Wound $135 2 payments
  9. INTEGRA DERMAL REGENERATION TEMPLATE $135 2 payments
  10. PRIMATRIX $135 2 payments
  11. Other $1,840 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

28

Median for Podiatry: 160

Drug cost

$343

Median for Podiatry: $2,368

Branded share of claims

50%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clotrimazole Generic 14 $195
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 14 $148

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$17,428

Medicare's payments for the services billed

Medicare patients

136

Average age 76

Services billed

351

89 women, 47 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 60%
Diabetes 33%
Ischemic heart disease 22%
Osteoporosis 22%
Atrial fibrillation 21%
Cancer 21%
Depression 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

77 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Rhode Island

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record